Main > NEUROLOGY. > Multiple Sclerosis > Treatment > TNF-Alpha Inhibitor > MAb Type TNF-Alpha Inhibitor > Patent > Claims > Claim 1: Multiple Sclerosis Treat.: > Adm. Monoclonal Anti-TNF Alpha > Antibody. Claim 3: Pharma Vehicle > Claim 4: Direct Adm. to CNS. Claim

---

Claim 4: Direct Adm. to CNS. Claim's subsections
5: Adm. IntraThecally. Claim 6:

Claim 4: Direct Adm. to CNS. Claim's products
This section has no products